Anti-CD30 bispecific antibody AATC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD30 bispecific antibody AATC, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies [Phase 1]